By Gina Shaw
Nearly all (98%) healthcare executives agree that drug diversion occurs in hospitals, and nearly four in five of them believe that most diversion goes undetected, according to a new survey from Invistics, now part of Wolters Kluwer.
The leaders who were most confident in their own drug diversion programs were those whose health systems used artificial intelligence tools to detect and flag suspicious patterns, with 53% reporting that they are very confident in the efficacy of